Brice Laffleur
Centre National de la Recherche Scientifique
ORCID: 0000-0003-2904-9345Also affiliated with Inserm, Université Rennes 2, Contrôle de la Réponse Immune B et Lymphoproliférations, Centre Hospitalier Universitaire de Rennes, Microenvironment and B-cells: Immunopathology, Cell, Differentiation and Cancer, Université de Rennes, Université de Limoges
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 3 papers. Top paper: “ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma”.
ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma
Andrew Chen, J. Robert Kane, Seong Jae Kang, Cynthia Kassab, Crismita Dmello +37 more
Junfei Zhao, Takashi Tsujiuchi, Brice Laffleur, Víctor A. Arrieta, Aayushi Mahajan +17 more
Brice Laffleur, Uttiya Basu, Kefei Yu, Junghyun Lim